Novavax, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Novavax, Inc. (NVAX) is 1.57B

According to Novavax, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.57B. This represents a change of 28.56% compared to the average of 1.22B of the last 4 quarters.

Novavax, Inc. (NVAX) Historical Enterprise Value (quarterly & annually)

How has NVAX Enterprise Value performed in the past?

The mean historical Enterprise Value of Novavax, Inc. over the last ten years is 2.05B. The current 1.57B Enterprise Value has changed 7.57% with respect to the historical average. Over the past ten years (40 quarters), NVAX's Enterprise Value was at its highest in in the June 2021 quarter at 14.09B. The Enterprise Value was at its lowest in in the December 2022 quarter at 33.47M.

Novavax, Inc. (NVAX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Novavax, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Novavax, Inc. (NVAX) Average Enterprise Value

How has NVAX Enterprise Value performed in the past?

The current Enterprise Value of Novavax, Inc. (NVAX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Novavax, Inc. (NVAX) Enterprise Value vs. Peers

How is NVAX’s Enterprise Value compared to its peers?

Novavax, Inc.’s Enterprise Value is greater than CureVac N.V. (533.40M), greater than Zenas BioPharma, Inc. (734.54M), less than Terns Pharmaceuticals, Inc. (4.25B), greater than Upstream Bio, Inc. (244.51M), greater than Wave Life Sciences Ltd. (656.32M), less than Trevi Therapeutics, Inc. (2.42B), less than Intellia Therapeutics, Inc. (1.70B), greater than Precigen, Inc. (1.54B), greater than Nektar Therapeutics (1.20B), greater than ORIC Pharmaceuticals, Inc. (825.76M),

Build a custom stock screener for Novavax, Inc. (NVAX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novavax, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novavax, Inc. (NVAX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novavax, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.